Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.
Vogelstein B, Fearon ER, Hamilton SR, et al. Genetic alterations during colorectal-tumor development. N Engl J Med. 1988;319:525–32.
Article CAS PubMed Google Scholar
Leggett B, Whitehall V. Role of the serrated pathway in colorectal cancer pathogenesis. Gastroenterology. 2010;138:2088–100.
Article CAS PubMed Google Scholar
Snover DC. Update on the serrated pathway to colorectal carcinoma. Hum Pathol. 2011;42:1–10.
Sweetser S, Smyrk TC, Sinicrope FA. Serrated colon polyps as precursors to colorectal cancer. Clin Gastroenterol Hepatol. 2013;11:760–7.
Sugai T, Habano W, Takagi R, et al. Analysis of molecular alterations in laterally spreading tumors of the colorectum. J Gastroenterol. 2017;52:715–23.
Article CAS PubMed Google Scholar
Jass JR. Classification of colorectal cancer based on correlation of clinical, morphological and molecular features. Histopathology. 2007;50:113–30.
Article CAS PubMed Google Scholar
Pai RK, Mäkinen MJ M, Rosty C. Colorectal serrated lesions and polyps. In: WHO classification of tumours editorial board (Ed.) WHO classification of tumours of the digestive system IARC, Lyon. 2019 pp.163–9.
Kambara T. BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum. Gut. 2004;53:1137–44.
Article CAS PubMed PubMed Central Google Scholar
Higuchi T, Sugihara K, Jass JR. Demographic and pathological characteristics of serrated polyps of colorectum. Histopathology. 2005;47:32–40.
Article CAS PubMed Google Scholar
O’Brien MJ, Yang S, Mack C, et al. Comparison of microsatellite instability, CpG Island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points. Am J Surg Pathol. 2006;30:1491–501.
Rosty C, Hewett DG, Brown IS, et al. Serrated polyps of the large intestine: current understanding of diagnosis, pathogenesis, and clinical management. J Gastroenterol. 2013;48:287–302.
Guinney J, Dienstmann R, Wang X, et al. The consensus molecular subtypes of colorectal cancer. Nat Med. 2015;21:1350–6.
Article CAS PubMed PubMed Central Google Scholar
Aderka D, Stintzing S, Heinemann V. Explaining the unexplainable: discrepancies in results from the CALGB/SWOG 80405 and FIRE-3 studies. Lancet Oncol. 2019;20:e274–83.
Lenz H-J, Ou F-S, Venook AP, et al. Impact of consensus molecular subtype on survival in patients with metastatic colorectal cancer: results from CALGB/SWOG 80405 (Alliance). J Clin Oncol. 2019;37:1876–85.
Article PubMed PubMed Central Google Scholar
Wallace K, Grau MV, Ahnen D, et al. The association of lifestyle and dietary factors with the risk for serrated polyps of the colorectum. Cancer Epidemiol Biomarkers Prev. 2009;18:2310–7.
Article PubMed PubMed Central Google Scholar
Jass JR, Whitehall VL, Young J, et al. Emerging concepts in colorectal neoplasia. Gastroenterology. 2002;123:862–76.
Article CAS PubMed Google Scholar
Lamb J. The connectivity map: using gene-expression signatures to connect small molecules, genes, and disease. Science. 2006;313:1929–35.
Article CAS PubMed Google Scholar
Jin L, Tu J, Jia J, et al. Drug-repurposing identified the combination of trolox C and cytisine for the treatment of type 2 diabetes. J Transl Med. 2014;12:153.
Article PubMed PubMed Central Google Scholar
Shigemizu D, Hu Z, Hung J-H, et al. Using functional signatures to identify repositioned drugs for breast, myelogenous leukemia and prostate cancer. PLoS Comput Biol. 2012;8: e1002347.
Article CAS PubMed PubMed Central Google Scholar
Musa A, Ghoraie LS, Zhang S-D, et al. A review of connectivity map and computational approaches in pharmacogenomics. Brief Bioinform. 2018;19:506–23.
Sato T, Stange DE, Ferrante M, et al. Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett’s epithelium. Gastroenterology. 2011;141:1762–72.
Article CAS PubMed Google Scholar
Sugimoto S, Ohta Y, Fujii M, et al. Reconstruction of the human colon epithelium in vivo. Cell Stem Cell. 2018;22(171–6): e5.
Kagamu H, Kitano S, Yamaguchi O, et al. CD4(+) T-cell immunity in the peripheral blood correlates with response to anti-PD-1 therapy. Cancer Immunol Res. 2020;8:334–44.
Article CAS PubMed Google Scholar
Kosaka T, Nagamatsu G, Saito S, et al. Identification of drug candidate against prostate cancer from the aspect of somatic cell reprogramming. Cancer Sci. 2013;104:1017–26.
Article CAS PubMed PubMed Central Google Scholar
Wada H, Sato Y, Fujimoto S, et al. Resveratrol inhibits development of colorectal adenoma via suppression of LEF1; comprehensive analysis with connectivity map. Cancer Sci. 2022;113:4374–84.
Article CAS PubMed PubMed Central Google Scholar
Takahashi S, Okamoto K, Tanahashi T, et al. S100P expression via DNA hypomethylation promotes cell growth in the sessile serrated adenoma/polyp-cancer sequence. Digestion. 2021;102:789–802.
Article CAS PubMed Google Scholar
Singh M, Dhindsa G, Friedland S, et al. Long-term use of proton pump inhibitors does not affect the frequency, growth, or histologic characteristics of colon adenomas. Aliment Pharmacol Ther. 2007;26:1051–61.
Article CAS PubMed Google Scholar
Johnson CC, Hayes RB, Schoen RE, et al. Non-steroidal anti-inflammatory drug use and colorectal polyps in the prostate, lung, colorectal, and ovarian cancer screening trial. Am J Gastroenterol. 2010;105:2646–55.
Article CAS PubMed PubMed Central Google Scholar
Carragher LA, Snell KR, Giblett SM, et al. V600EBraf induces gastrointestinal crypt senescence and promotes tumour progression through enhanced CpG methylation of p16INK4a. EMBO Mol Med. 2010;2:458–71.
Article CAS PubMed PubMed Central Google Scholar
Sakamoto N, Feng Y, Stolfi C, et al. BRAF(V600E) cooperates with CDX2 inactivation to promote serrated colorectal tumorigenesis. Elife. 2017;6:e20331.
Article PubMed PubMed Central Google Scholar
Lannagan TRM, Lee YK, Wang T, et al. Genetic editing of colonic organoids provides a molecularly distinct and orthotopic preclinical model of serrated carcinogenesis. Gut. 2019;68:684–92.
Article CAS PubMed Google Scholar
Bond CE, Liu C, Kawamata F, et al. Oncogenic BRAF mutation induces DNA methylation changes in a murine model for human serrated colorectal neoplasia. Epigenetics. 2018;13:40–8.
Article PubMed PubMed Central Google Scholar
Shimokawa M, Ohta Y, Nishikori S, et al. Visualization and targeting of LGR5(+) human colon cancer stem cells. Nature. 2017;545:187–92.
Article CAS PubMed Google Scholar
Kikuchi H, Kato H, Mizuno M, et al. Differences in inducibility of CYP1A1-mRNA by benzimidazole compounds between human and mouse cells: evidences of a human-specific signal transduction pathway for CYP1A1 induction. Arch biochem biophys. 1996;334:235–40.
Article CAS PubMed Google Scholar
Hume S, Grou CP, Lascaux P, et al. The NUCKS1-SKP2-p21/p27 axis controls S phase entry. Nat Commun. 2021;12:6959.
Article CAS PubMed PubMed Central Google Scholar
Luciani F, Spada M, De Milito A, et al. Effect of proton pump inhibitor pretreatment on resistance of solid tumors to cytotoxic drugs. J Natl Cancer Inst. 2004;96:1702–13.
Article CAS PubMed Google Scholar
De Milito A, Canese R, Marino ML, et al. pH-dependent antitumor activity of proton pump inhibitors against human melanoma is mediated by inhibition of tumor acidity. Int J Cancer. 2010;127:207–19.
Patlolla JM, Zhang Y, Li Q, et al. Anti-carcinogenic properties of omeprazole against human colon cancer cells and azoxymethane-induced colonic aberrant crypt foci formation
Comments (0)